CXCR4 and Miyoshi myopathy: In MM, CXCR4 triggers the onset of distant manifestations, such as by osteoclastogenesis and multidrug resistance (46), suggesting that targeting of this receptor may provide not only an improved diagnostic read-out but also prognostic capabilities (39).